| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CBSTF | Common Shares | Sale | -$53K | -150K | -0.72% | $0.35 | 20.8M | Dec 4, 2023 | Held by Vita Holdings LLC | F1, F3 |
| transaction | CBSTF | Common Shares | Sale | -$70.9K | -200K | -0.96% | $0.35 | 20.6M | Dec 5, 2023 | Held by Vita Holdings LLC | F2, F3 |
| holding | CBSTF | Common Shares | 619K | Dec 4, 2023 | Direct |
| Id | Content |
|---|---|
| F1 | The sales price reported above was converted from the Canadian weighted average price of $0.478333 using an exchange rate of C$1.3541 = US$1.00. These shares were sold in multiple transactions at prices ranging from C$0.47 to $0.485, inclusive. The Reporting Person undertakes to provide to The Cannabist Company Holdings Inc., any security holder of The Cannabist Company Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F2 | The sale price reported above was converted from the Canadian weighted average price of C$0.48125 using an exchange rate of C$1.3579 = US$1.00. These shares were sold in multiple transactions at price ranging from C$0.48 to $0.485, inclusive. The Reporting Person undertakes to provide to The Cannabist Company Holdings Inc., any security holder of The Cannabist Company Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| F3 | Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, education and philanthropic purposes. |